GO Treatment Market Growth Catalyzed by Novel IGF-1R Inhibitors and...

added blog Health

2025-10-17 12:07:34

GO Treatment Market Growth Catalyzed by Novel IGF-1R Inhibitors and Targeted Therapies

The global Graves ophthalmopathy (GO) treatment market growth was valued at US$ 2.09 billion in 2024 and is projected to reach US$ 3.01 billion by 2033, growing at a CAGR of 4.2% during the forecast period. Download Sample PDF: Market Overview Graves ophthalmopathy, also known as thyroid eye disease (TED), is a serious autoimmune condition affecting the orbit around the eyes. It...

0 Comments 0 Shares 231 Views 0 Reviews